Document Detail


The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
MedLine Citation:
PMID:  23449428     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of this study was to evaluate the relationship between left ventricular (LV) ejection fraction and clinical outcome to cardiac resynchronization therapy (CRT) in mild heart failure patients enrolled in MADIT-CRT [corrected].
BACKGROUND: Left ventricular ejection fraction (LVEF) is a surrogate marker of heart failure (HF) status and associated risk. Data on the effectiveness of cardiac resynchronization therapy with defibrillator (CRT-D) in patients with mild HF and better LVEF are limited.
METHODS: In the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study, the echocardiography core laboratory assessed baseline LVEF independent of the enrolling centers and identified a range of LVEFs, including those >30% (i.e., beyond the eligibility criteria). Echocardiographic response with CRT, defined as percent change in left ventricular end-diastolic volume (LVEDV), was analyzed in 3 prespecified LVEF groups: >30%, 26% to 30%, and ≤25%. The primary endpoint was HF or death. Secondary endpoint included all-cause mortality.
RESULTS: LVEF was evaluated in 1,809 study patients. There were 696 (38%) patients with LVEF >30% (in the range of 30.1% to 45.3%); 914 patients (50.5%) with LVEF 26% to 30%; and 199 patients with LVEF ≤25% (11%). The mean reduction in LVEDV with CRT-D therapy at the 1-year follow-up was directly related to increasing LVEF (LVEF >30%: 22.3%; LVEF 26% to 30%: 20.1%; and LVEF ≤25%: 18.7% reduction, respectively [p = 0.001]). CRT-D treatment similarly reduced the risk of HF/death in patients with LVEF >30% (hazard ratio [HR]: = 0.56 [95% confidence interval (CI): 0.39 to 0.82], p = 0.003), LVEF 26% to 30% (HR: 0.67: [95% CI: 0.50 to 0.90], p = 0.007), and LVEF ≤25% (HR: 0.57 [95% CI: 0.35 to 0.95], p = 0.03; all p values for LVEF-by-treatment interactions >0.1).
CONCLUSIONS: In MADIT-CRT, the clinical benefit of CRT was evident regardless of baseline LVEF, including those with LVEF >30%, whereas the echocardiographic response was increased with increasing LVEF, indicating that CRT might benefit patients with better LVEF. (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271).
Authors:
Valentina Kutyifa; Axel Kloppe; Wojciech Zareba; Scott D Solomon; Scott McNitt; Slava Polonsky; Alon Barsheshet; Bela Merkely; Bernd Lemke; Vivien Klaudia Nagy; Arthur J Moss; Ilan Goldenberg
Related Documents :
23139358 - Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart fun...
20362728 - The outcome of primary percutaneous coronary intervention for stent thrombosis causing ...
23740218 - Novel aspects of excitation-contraction coupling in heart failure.
24535438 - Passive hind-limb cycling improves cardiac function and reduces cardiovascular disease ...
8571418 - Reduced heart rate variability after right-sided stroke.
11826838 - Balance and imbalance of regional myocardial contractile function and blood flow.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  61     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-01     Completed Date:  2013-04-15     Revised Date:  2013-06-24    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  936-44     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
University of Rochester Medical Center, Rochester, New York; Semmelweis University, Heart Center, Budapest, Hungary. valentina.kutyifa@heart.rochester.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiac Resynchronization Therapy*
Defibrillators, Implantable*
Echocardiography
Female
Follow-Up Studies
Heart Failure
Humans
Male
Middle Aged
Stroke Volume / physiology*
Comments/Corrections
Comment In:
J Am Coll Cardiol. 2013 Mar 5;61(9):945-7   [PMID:  23449429 ]
Erratum In:
J Am Coll Cardiol. 2013 Apr 2;61(13):1469

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High-dose allopurinol reduces left ventricular mass in patients with ischemic heart disease.
Next Document:  Metformin impairs vascular endothelial recovery after stent placement in the setting of locally elut...